Literature DB >> 33362449

An Emphasis on Screening to Detect Liver Cirrhosis and Hepatocellular Carcinoma in Patients Having Undergone the Fontan Procedure in Early Childhood.

Samragnyi Madala1, Kira MacDougall1, Abhishek Polavarapu2, Dinesh Gurala1, Vivek Gumaste2, Gerard Morvillo3.   

Abstract

The Fontan procedure is a surgical procedure for patients with single-ventricle anatomy that results in the flow of systemic venous blood to the lungs without passing through a ventricle. Before the 1970s, most children with single-ventricle anatomy failed to survive into adulthood. With the introduction of the Fontan procedure, and its many modifications, the survival rate of these patients improved exponentially. With patients surviving longer, complications from this procedure are being documented for the first time. Cardiovascular complications are expected early on and are well studied. More serious are the non-cardiovascular complications in patients who survive into adulthood. The biggest entity is Fontan-associated liver disease (FALD) which needs thorough monitoring to screen for hepatocellular carcinoma (HCC). FALD includes chronic passive congestion, liver cirrhosis, and HCC. Once cirrhosis develops, monitoring with annual liver function tests, AFP, and abdominal ultrasonography need to occur to screen for HCC. Patients may need to be evaluated for combined heart-liver transplantation. Strict guidelines need to be developed for monitoring and surveillance of these patients to prevent late-stage complications. Herein, we report a unique case of FALD in a young female presenting two decades after the procedure with variceal bleeding.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Fontan procedure; Fontan-associated liver disease; Hypoplastic left ventricle

Year:  2020        PMID: 33362449      PMCID: PMC7747073          DOI: 10.1159/000510332

Source DB:  PubMed          Journal:  Case Rep Gastroenterol        ISSN: 1662-0631


  13 in total

1.  Medical factors that predict quality of life for young adults with congenital heart disease: What matters most?

Authors:  Jamie L Jackson; Lauren Hassen; Gina M Gerardo; Kathryn Vannatta; Curt J Daniels
Journal:  Int J Cardiol       Date:  2015-09-30       Impact factor: 4.164

Review 2.  Liver disease in the patient with Fontan circulation.

Authors:  Fred M Wu; Chinweike Ukomadu; Robert D Odze; Anne Marie Valente; John E Mayer; Michael G Earing
Journal:  Congenit Heart Dis       Date:  2011-03-28       Impact factor: 2.007

Review 3.  Fontan-Associated Liver Disease: A Review.

Authors:  Luis Téllez; Enrique Rodríguez-Santiago; Agustín Albillos
Journal:  Ann Hepatol       Date:  2018-03-01       Impact factor: 2.400

4.  The Fontan procedure: anatomy, complications, and manifestations of failure.

Authors:  Tyler B Fredenburg; Tiffanie R Johnson; Mervyn D Cohen
Journal:  Radiographics       Date:  2011 Mar-Apr       Impact factor: 5.333

5.  Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.

Authors:  Amir A Ghaferi; Grover M Hutchins
Journal:  J Thorac Cardiovasc Surg       Date:  2005-06       Impact factor: 5.209

6.  MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.

Authors:  Douglas M Heuman; Anastasios A Mihas; Adil Habib; Hochong S Gilles; R Todd Stravitz; Arun J Sanyal; Robert A Fisher
Journal:  Liver Transpl       Date:  2007-01       Impact factor: 5.799

7.  Fontan Liver Disease: Review of an Emerging Epidemic and Management Options.

Authors:  Elisa Bradley; Benjamin Hendrickson; Curt Daniels
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

8.  MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.

Authors:  Gabriele Egidy Assenza; Dionne A Graham; Michael J Landzberg; Anne Marie Valente; Michael N Singh; Aamir Bashir; Susan Fernandes; Koenraad J Mortele; Chinweike Ukomadu; Massimo Volpe; Fred Wu
Journal:  Heart       Date:  2013-02-13       Impact factor: 5.994

9.  Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study.

Authors:  Robert W Elder; Nancy M McCabe; Camden Hebson; Emir Veledar; Rene Romero; Ryan M Ford; William T Mahle; Brian E Kogon; Anurag Sahu; Maan Jokhadar; Michael E McConnell; Wendy M Book
Journal:  Int J Cardiol       Date:  2013-07-09       Impact factor: 4.164

10.  Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: A case report.

Authors:  Chaeyoun Oh; Joong Kee Youn; Ji-Won Han; Gi Beom Kim; Hyun-Young Kim; Sung-Eun Jung
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.